A specific B2-bradykinin receptor antagonist HOE 140 abolishes the antihypertrophic effect of ramipril
about
Ramipril prevents left ventricular hypertrophy with myocardial fibrosis without blood pressure reduction: a one year study in ratsAssociation of genetic factors with selected measures of physical performance.Towards understanding the kallikrein-kinin system: insights from measurement of kinin peptides.Do we need more than just powerful blood pressure reductions? New paradigms in end-organ protectionTherapeutic potential of ACE inhibitors for the treatment of hypertension in Type 2 diabetes.Inhibition of CatA: an emerging strategy for the treatment of heart failure.Association between ACE D allele and elite short distance swimming.The causes, consequences, and treatment of left or right heart failureCardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity.Kinin B2 receptor is not involved in enalapril-induced apoptosis and regression of hypertrophy in spontaneously hypertensive rat aorta: possible role of B1 receptor.Synergistic interaction between enalapril, L-arginine and tetrahydrobiopterin in smooth muscle cell apoptosis and aortic remodeling induction in SHR.The kallikrein-kinin system as a regulator of cardiovascular and renal function.Preventing left ventricular hypertrophy by ACE inhibition in hypertensive patients with type 2 diabetes: a prespecified analysis of the Bergamo Nephrologic Diabetes Complications Trial (BENEDICT).Evidence-based treatment of chronic heart failure.Icatibant , the bradykinin B2 receptor antagonist with target to the interconnected kinin systems.Nitric oxide-based possibilities for pharmacotherapy.Endostatin inhibits bradykinin-induced cardiac contraction.Role of bradykinin in the antihypertensive and cardioprotective actions of converting enzyme inhibitors.Angiotensin converting enzyme (ACE) inhibitors and kinin metabolism: evidence that ACE inhibitors may inhibit a kininase other than ACE.Ramiprilat increases bradykinin outflow from isolated hearts of rat.Lack of correlation of hypotensive effects with prevention of cardiac hypertrophy by perindopril after ligation of rat coronary artery.Effects of bradykinin B2 receptor antagonism on the hypotensive effects of ACE inhibition.Lack of involvement of bradykinin in the vascular sympathoinhibitory effects of angiotensin converting enzyme inhibitors in spontaneously hypertensive ratsEnalapril decreases cardiac mass and fetal gene expression without affecting the expression of endothelin-1, transforming growth factor β-1, or cardiotrophin-1 in the healthy normotensive rat.Nephroprotection in Zucker diabetic fatty rats by vasopeptidase inhibition is partly bradykinin B2 receptor dependent.Role of nitric oxide in responses to renin-angiotensin system inhibition in sodium-depleted guinea pig and rat.The cardioprotective effect of dual metallopeptidase inhibition: respective roles of endogenous kinins and natriuretic peptides.Both enalapril and losartan attenuate sarcolemmal Na+-K+-ATPase remodeling in failing rat heart due to myocardial infarction.Production of eicosanoids and angiotensin II in resistance vessels in spontaneously hypertensive rats.
P2860
Q33189269-F046658D-F94F-4680-9AB1-65A420539638Q33875361-187FAF0E-FDC3-4F22-BB9A-7328267EC134Q33928318-7F244102-EC05-4040-AAEB-52F16C242A5EQ34068728-E0F0D30E-F943-49AE-8FD7-FBBC571B2947Q34075171-3F48E0F6-D9C7-4EC5-A93E-E745B302F686Q34621201-A82EC84D-21DE-4E9E-A8D3-1947278CCAD9Q34982298-1BA68095-F582-4A71-A6EB-3FE5AD328EF3Q34987168-7A9C2134-9BE5-42ED-AC3C-F3753209E8A6Q35035923-6F2B5681-2247-4B0B-B7DD-62CF667BFA23Q35046131-B5A28DC1-B365-4C73-ABB5-5B3FFCF98846Q35047327-F47DC433-D8AC-454B-B072-2BBD0B9E9A06Q36389061-CE28E08C-9FD5-4BE9-BBF0-981D22E538E5Q36807421-18F6476B-E02C-47D2-9300-2BEAC21F74EEQ36993970-78D4EEF0-68A7-4B30-B427-EB1F508ECC78Q38042696-7906A4B9-E6EC-46C5-B7F4-133A748E130DQ40405202-637925D5-9BBE-4CBC-A2C3-435AA0888A27Q40862113-6772064E-DC3B-483C-82D0-81045A4ACD49Q41143381-7B6DAEF7-4FCB-4A57-AF19-EF7A5A7C94ADQ41143573-1F753F99-C269-4B64-AE9E-353AFDBD8F75Q41770180-E9C124FB-8E66-452E-AD20-4071E92AB3C9Q41788306-B9FF8355-A50C-4F9B-88D4-819B5ED60349Q42370456-A5491020-5080-4740-9DE5-D0D0AB93F8B5Q42708325-80E81907-BFDB-4FA2-A56A-655F49478128Q42745465-7EF70DE1-4541-4340-A133-F917F4E58FF1Q43262211-966A575E-C140-45D4-BEA5-EF9B72C9A1F3Q46163560-9E42248D-0E01-44D5-9684-F1F774EE89AEQ46404773-BC87FD66-1638-410E-B42E-3634CC8FDDA7Q46640308-597FBD4F-53A2-4DB3-9EFA-60B521C7A384Q47804118-E5FF8A64-30AE-4E45-9AD0-C307315E4C93
P2860
A specific B2-bradykinin receptor antagonist HOE 140 abolishes the antihypertrophic effect of ramipril
description
1992 nî lūn-bûn
@nan
1992 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
A specific B2-bradykinin recep ...... ypertrophic effect of ramipril
@ast
A specific B2-bradykinin recep ...... ypertrophic effect of ramipril
@en
type
label
A specific B2-bradykinin recep ...... ypertrophic effect of ramipril
@ast
A specific B2-bradykinin recep ...... ypertrophic effect of ramipril
@en
prefLabel
A specific B2-bradykinin recep ...... ypertrophic effect of ramipril
@ast
A specific B2-bradykinin recep ...... ypertrophic effect of ramipril
@en
P2860
P1476
A specific B2-bradykinin recep ...... ypertrophic effect of ramipril
@en
P2093
P2860
P304
P356
10.1111/J.1476-5381.1992.TB09054.X
P407
P577
1992-04-01T00:00:00Z